Sitagliptin Grindeks
This medicine helps lower high blood sugar in adults with type 2 diabetes by increasing insulin after meals and reducing sugar made by the body.
Form
tabletti, kalvopäällysteinen
Strength
25 mg
Active Ingredient
Sitagliptin hydrochloride monohydrate
Manufacturer
Grindeks AS
How to Use
Dosage
One 100 mg tablet once a day.
Method
Take by mouth, with or without food.
Important
The usual maximum daily dose is 100 mg. Do not take more than prescribed.
Possible Side Effects
COMMON
- •Low blood sugar
- •Nausea
- •Flatulence
- •Vomiting
- •Constipation
- •Swollen hands or feet
- •Common cold (nasopharyngitis)
- •Headache
- •Upper respiratory tract infection
- •Stuffy or runny nose and sore throat
- •Osteoarthritis
- •Pain in arms or legs
RARE
- •Stomach pain
- •Diarrhea
- •Drowsiness
- •Dry mouth
- •Dizziness
- •Itching
- •Reduced number of platelets
Important Warnings
- Do not take if you are allergic to sitagliptin or any other ingredient in this medicine.
- This medicine may cause serious inflammation of the pancreas (pancreatitis). If you get severe stomach pain that does not go away, stop taking the medicine and contact your doctor right away.
- If you develop blisters or peeling skin, stop taking this medicine and contact your doctor.
- Tell your doctor if you have or have had problems with your pancreas (like pancreatitis), gallstones, alcoholism, very high levels of blood fats (triglycerides), type 1 diabetes, diabetic ketoacidosis (a serious diabetes complication), or kidney problems.
- If you have a severe allergic reaction (such as rash, hives, skin blisters, swelling of the face, lips, tongue, or throat that makes it hard to breathe or swallow), stop taking this medicine and get medical help right away.
Show 2 more warnings
- Children and teenagers under 18 years old should not use this medicine.
- Do not take this medicine if you are pregnant, planning to become pregnant, or are breastfeeding.
Use in Elderly Patients
Category C
Suitable for older adults, with specific precautions. Reduce the dose in moderately severe renal impairment. (updated 10.6.2024)